Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs].

Authors : Bron D, de Wind R, Cantinieaux B, Woff E, Roelandts M, Moerman C, Lemort M, Heimann P, de Wilde V, Meuleman N, Maerevoet M
Year : 2015
Journal : Rev Med Brux
Volume : 36
Pages : 237-47

Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.

Authors : de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Hernández SB, Shih-Li C, Delhaye F, Focan C, Cornez N, Vindevoghel A, Beauduin M, Lemort M, Paesmans M, Suter T, Piccart-Gebhart M
Year : 2015
Journal : Eur J Cancer
Volume : 51
Pages : 2517-24

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.

Authors : Deleporte A, Paesmans M, Garcia C, Vandeputte C, Lemort M, Engelholm JL, Hoerner F, Aftimos P, Awada A, Charette N, Machiels G, Piccart-Gebhart M, Flamen P, Hendlisz A
Year : 2014
Journal : BMC Cancer
Volume : 14(1)
Pages : 385

Primary Zonal High Intensity Focused Ultrasound for Prostate Cancer: Results of a Prospective Phase IIa Feasibility Study.

Authors : Van Velthoven R, Aoun F, Limani K, Narahari K, Lemort M, Peltier A
Year : 2014
Journal : Prostate Cancer
Volume : 2014(null)
Pages : 756189

Cardiac metastase of a soft tissue sarcoma: a case report and a review of the literature.

Authors : Polastro L, de Saint-Aubain de Somerhausen N, Lemort M, Delhaye F, Awada A
Year : 2014
Journal : Rev Med Brux
Volume : 35(6)
Pages : 499-503

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.

Authors : de Azambuja E, Zardavas D, Lemort M, Rossari J, Moulin C, Buttice A, Dhondt V, Lebrun F, Lalami Y, Cardoso F, Sotiriou C, Gil T, Devriendt D, Paesmans M, Piccart-Gebhart M, Awada A
Year : 2013
Journal : Ann Oncol
Volume : 24(12)
Pages : 2985-9

Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.

Authors : Lagemaat MW, Zechmann CM, Fütterer JJ, Weiland E, Lu J, Villeirs GM, Holshouser BA, van Hecke P, Lemort M, Schlemmer HP, Barentsz JO, Roell SO, Heerschap A, Scheenen TW
Year : 2012
Journal : J Magn Reson Imaging
Volume : 35(1)
Pages : 166-73

Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.

Authors : Goris Gbenou M, Peltier A, Addla SK, Lemort M, Bollens R, Larsimont D, Roumeguère T, Schulman CC, Van Velthoven R
Year : 2012
Journal : Urol. Int.
Volume : 88(1)
Pages : 12-7

New Imaging Techniques for 90Y Microsphere Radioembolization.

Authors : Vouche M, Vanderlinden B, Delatte P, Lemort M, Hendlisz A, Deleporte A, Garcia C, Flamen P
Year : 2011
Journal : J Nucl Med Radiat Ther
Volume : 2
Pages : 113

Non Hodgkin's lymphomas: a major breakthrough with immunotherapy].

Authors : Firescu R, Muylle K, Roelandts M, de Wind A, Moerman C, Lemort M, Kentos A, Meuleman N, Bron D
Year : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pages : 83-92

Parathyroid carcinoma: a review with three illustrative cases.

Authors : Digonnet A, Carlier A, Willemse E, Quiriny M, Dekeyser C, de Saint-Aubain de Somerhausen N, Lemort M, Andry G
Year : 2011
Journal : J Cancer
Volume : 2(null)
Pages : 532-7